Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 March 2006

Lipoprotein(a) and lipid profile in patients with atrial fibrillation.

José Antonio Díaz-Peromingo, Ana Albán-Salgado, Florinda García-Suárez, Joaquín Sánchez-Leira, Juan Saborido-Froján, Marina Iglesias-Gallego

Med Sci Monit 2006; 12(3): CR122-125 :: ID: 447110

Abstract

Background: Atrial fibrillation (AF) is well-known risk factor for cardiacembolic events, especially cerebrovascular events. The association between AF and lipid markers was evaluated.Among all these markers, lipoprotein(a), or (Lp(a), was also investigated. The aim of our study was toevaluate the characteristics of the lipid profile in patients with AF, focusing on Lp(a) levels. Material/Methods:One hundred and one patients with AF were included in the study group. We used 101 patients without AF,matched by sex and age with the study group, as the control group. Total cholesterol, low-density lipoproteincholesterol, high-density lipoprotein cholesterol, triglycerides, Lp(a), and the LDL/HDL, COL/LDL, andCOL/HDL indexes were measured. The study was performed in Spain with a Caucasian population. Results:Among all the variables included there was statistical difference only between groups in the COL/HDLindex, showing a greater value in the group of patients with AF. No difference was found in Lp(a) levelsbetween the groups. Conclusions: Although some studies have tried to show a possible relationship betweenAF and high Lp(a) levels, we found no such relationship in our study, although ethnic differences couldexplain, at least in part, these results in our patients when compared with other ethnic populations.

Keywords: European Continental Ancestry Group - genetics, Triglycerides - genetics, Risk Factors, Lipoproteins, LDL - genetics, Lipoprotein(a) - genetics, Lipids - genetics, Atrial Fibrillation, Enzyme-Linked Immunosorbent Assay, Cholesterol, LDL - genetics, Cholesterol, HDL - genetics, Cholesterol - genetics, Case-Control Studies, Biological Markers - blood

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

18 Mar 2024 : Clinical Research  

Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944136  

0:00

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750